Successful treatment with mecobalamin in a pernicious anemia patient presenting with false-normal serum vitamin B12

DOI Web Site PubMed

Bibliographic Information

Other Title
  • 血清ビタミンB12が正常値を呈しmecobalamin投与によって改善した悪性貧血
  • 症例報告 血清ビタミンB12が正常値を呈しmecobalamin投与によって改善した悪性貧血
  • ショウレイ ホウコク ケッセイ ビタミン B12 ガ セイジョウチ オ テイシ mecobalamin トウヨ ニ ヨッテ カイゼン シタ アクセイ ヒンケツ

Search this article

Description

<p>An 81-year-old woman presented to our hospital with anemia. Complete blood counts revealed macrocytic anemia; however, serum vitamin B12 and folate levels were normal. Bone marrow aspiration revealed multilineage dysplasia, and the patient was initially diagnosed with refractory cytopenia and multilineage dysplasia subtype of myelodysplastic syndrome. However, blood smear revealed hypersegmented neutrophils and bone marrow aspiration showed remarkable megaloblastic changes of erythroid cells. Based on these findings, the patient was administered 1,500 µg mecobalamin per day on a trial basis. Three weeks after initiating mecobalamin, macrocytic anemia improved. Her hemoglobin levels were also normalized along with immediate resolution of peripheral blood dysplasia. The final diagnosis was pernicious anemia (PA) based on anti-intrinsic factor positivity and the efficacy of mecobalamin. Use of automated analyzers may be associated with falsely normal or falsely elevated vitamin B12 levels in the presence of anti-intrinsic factor antibodies. Our case suggests that trial administration of mecobalamin may be an important step to correctly diagnose PA associated with falsely normal or falsely elevated vitamin B12 levels, particularly when typical morphological features of PA are present.</p>

Journal

  • Rinsho Ketsueki

    Rinsho Ketsueki 59 (6), 675-681, 2018

    The Japanese Society of Hematology

Keywords

Details 詳細情報について

Report a problem

Back to top